NASDAQ:GOSS

Gossamer Bio News Headlines

$8.84
-0.09 (-1.01 %)
(As of 06/11/2021 12:00 AM ET)
Add
Compare
Today's Range
$8.73
$9.03
50-Day Range
$8.00
$9.75
52-Week Range
$7.63
$15.42
Volume351,229 shs
Average Volume472,932 shs
Market Capitalization$671.04 million
P/E RatioN/A
Dividend YieldN/A
Beta1.23

Gossamer Bio (NASDAQ GOSS) News Headlines Today

SourceHeadline
Gossamer Bio, Inc. (NASDAQ:GOSS) Given Consensus Recommendation of "Buy" by BrokeragesGossamer Bio, Inc. (NASDAQ:GOSS) Given Consensus Recommendation of "Buy" by Brokerages
americanbankingnews.com - May 27 at 1:38 AM
Gossamer Bio (NASDAQ:GOSS) Stock Price Up 2.4%Gossamer Bio (NASDAQ:GOSS) Stock Price Up 2.4%
americanbankingnews.com - May 19 at 10:54 AM
Gossamer Bio Announces First Quarter 2021 Financial Results and Provides Corporate UpdateGossamer Bio Announces First Quarter 2021 Financial Results and Provides Corporate Update
finance.yahoo.com - May 6 at 2:19 PM
Gossamer Bios chief scientific officer Luisa Salter-Cid to resignGossamer Bio's chief scientific officer Luisa Salter-Cid to resign
seekingalpha.com - April 21 at 8:55 PM
Gossamer Bio Announces Executive Management Transition and Promotion of Laura Carter, Ph.D., to Chief Scientific OfficerGossamer Bio Announces Executive Management Transition and Promotion of Laura Carter, Ph.D., to Chief Scientific Officer
finance.yahoo.com - April 20 at 12:40 PM
Gossamer Bio Announces Promotion of Caryn Peterson to Executive Vice President, Regulatory AffairsGossamer Bio Announces Promotion of Caryn Peterson to Executive Vice President, Regulatory Affairs
finance.yahoo.com - April 16 at 12:30 PM
Dont Ignore The Fact That This Insider Just Sold Some Shares In Gossamer Bio, Inc. (NASDAQ:GOSS)Don't Ignore The Fact That This Insider Just Sold Some Shares In Gossamer Bio, Inc. (NASDAQ:GOSS)
nasdaq.com - April 1 at 8:55 AM
Just say ehhhhh: When it comes to the lucrative U.S. drug discovery market, Canadians are everywhereJust say ehhhhh: When it comes to the lucrative U.S. drug discovery market, Canadians are everywhere
theglobeandmail.com - March 25 at 7:42 AM
Gossamer Bio to Announce Fourth Quarter and Full-Year 2020 Financial Results and Host Conference Call and Webcast on February 25, 2021Gossamer Bio to Announce Fourth Quarter and Full-Year 2020 Financial Results and Host Conference Call and Webcast on February 25, 2021
finance.yahoo.com - February 19 at 8:58 AM
Gossamer Bio to Host Webcast Focused on its Inflammatory Bowel Disease Program, GB004, on February 18, 2021Gossamer Bio to Host Webcast Focused on its Inflammatory Bowel Disease Program, GB004, on February 18, 2021
finance.yahoo.com - February 4 at 7:38 AM
Have Insiders Been Buying Gossamer Bio, Inc. (NASDAQ:GOSS) Shares This Year?Have Insiders Been Buying Gossamer Bio, Inc. (NASDAQ:GOSS) Shares This Year?
finance.yahoo.com - January 19 at 5:58 PM
GOSS Jan 2021 15.000 putGOSS Jan 2021 15.000 put
uk.finance.yahoo.com - December 22 at 10:11 PM
GOSS Jan 2021 7.500 callGOSS Jan 2021 7.500 call
uk.finance.yahoo.com - December 22 at 10:11 PM
Is GOSS A Good Stock To Buy Now According To Hedge Funds?Is GOSS A Good Stock To Buy Now According To Hedge Funds?
finance.yahoo.com - December 19 at 5:51 PM
Gossamer Bio to Host Webcast Focused on GB002 and Pulmonary Arterial Hypertension (PAH) on December 15, 2020Gossamer Bio to Host Webcast Focused on GB002 and Pulmonary Arterial Hypertension (PAH) on December 15, 2020
finance.yahoo.com - December 7 at 1:27 PM
GOSS Dec 2020 7.500 callGOSS Dec 2020 7.500 call
ca.finance.yahoo.com - December 5 at 6:30 PM
GOSS May 2021 15.000 callGOSS May 2021 15.000 call
ca.finance.yahoo.com - December 4 at 9:48 PM
GOSS May 2021 17.500 putGOSS May 2021 17.500 put
ca.finance.yahoo.com - December 4 at 9:48 PM
Taking A Gander At Gossamer BioTaking A Gander At Gossamer Bio
seekingalpha.com - November 18 at 6:13 PM
Gossamer Bio Announces Appointment of Faheem Hasnain as Chief Executive OfficerGossamer Bio Announces Appointment of Faheem Hasnain as Chief Executive Officer
finance.yahoo.com - November 16 at 9:56 AM
Gossamer Bio, Inc. (GOSS) CEO Sheila Gujrathi on Q3 2020 Results - Earnings Call TranscriptGossamer Bio, Inc. (GOSS) CEO Sheila Gujrathi on Q3 2020 Results - Earnings Call Transcript
seekingalpha.com - November 11 at 4:42 AM
Gossamer Bio EPS beats by $0.04Gossamer Bio EPS beats by $0.04
seekingalpha.com - November 10 at 6:13 PM
Gossamer Bio, Inc. to Host Earnings CallGossamer Bio, Inc. to Host Earnings Call
finance.yahoo.com - November 10 at 6:13 PM
Gossamer Bio Announces Third Quarter 2020 Financial Results and Provides Corporate UpdateGossamer Bio Announces Third Quarter 2020 Financial Results and Provides Corporate Update
finance.yahoo.com - November 10 at 6:13 PM
Aerpio Pharmaceuticals, Inc. (ARPO) Management on Q3 2020 Results - Earnings Call TranscriptAerpio Pharmaceuticals, Inc. (ARPO) Management on Q3 2020 Results - Earnings Call Transcript
seekingalpha.com - November 10 at 1:09 PM
The Week Ahead In Biotech: Supernus, Sanofi Await FDA DecisionsThe Week Ahead In Biotech: Supernus, Sanofi Await FDA Decisions
msn.com - November 8 at 3:44 PM
Gossamer Bio Announces GB1275 Data Presentations at 2020 Society for Immunotherapy of Cancer Annual MeetingGossamer Bio Announces GB1275 Data Presentations at 2020 Society for Immunotherapy of Cancer Annual Meeting
finance.yahoo.com - November 6 at 10:13 AM
Gossamer Bio to Announce Third Quarter 2020 Financial Results and Host Conference Call and Webcast on November 10, 2020Gossamer Bio to Announce Third Quarter 2020 Financial Results and Host Conference Call and Webcast on November 10, 2020
finance.yahoo.com - November 6 at 10:13 AM
Gossamer Bio Announces Presentation of GB004 Phase 1b Clinical Data at United European Gastroenterology Virtual Week 2020 and Additional Program UpdatesGossamer Bio Announces Presentation of GB004 Phase 1b Clinical Data at United European Gastroenterology Virtual Week 2020 and Additional Program Updates
finance.yahoo.com - October 22 at 3:31 AM
Insider Weekends: Director Of Selecta Biosciences Purchases Over Half A Million Dollars Worth Of StockInsider Weekends: Director Of Selecta Biosciences Purchases Over Half A Million Dollars' Worth Of Stock
seekingalpha.com - October 19 at 7:35 AM
Hedge Funds Are Piling Into Gossamer Bio, Inc. (GOSS)Hedge Funds Are Piling Into Gossamer Bio, Inc. (GOSS)
finance.yahoo.com - October 18 at 2:32 PM
Stock Alert: Bio Tanks 33%Stock Alert: Bio Tanks 33%
nasdaq.com - October 13 at 4:48 PM
Gossamer Bios GB001 flunks both asthma and rhinosinusitis studiesGossamer Bio's GB001 flunks both asthma and rhinosinusitis studies
seekingalpha.com - October 13 at 4:48 PM
Gossamers Phase 2 Trials Of Oral GB001 In Asthma And Chronic Rhinosinusitis Fail To Meet Main GoalGossamer's Phase 2 Trials Of Oral GB001 In Asthma And Chronic Rhinosinusitis Fail To Meet Main Goal
nasdaq.com - October 13 at 4:48 PM
Gossamer Bio Is Sucking Wind After This Asthma StudyGossamer Bio Is Sucking Wind After This Asthma Study
msn.com - October 13 at 4:48 PM
Gossamer Bios GB004 shows positive action in early-stage ulcerative colitis studyGossamer Bio's GB004 shows positive action in early-stage ulcerative colitis study
seekingalpha.com - October 12 at 4:22 PM
Are Options Traders Betting on a Big Move in Gossamer Bio (GOSS) Stock?Are Options Traders Betting on a Big Move in Gossamer Bio (GOSS) Stock?
nasdaq.com - September 30 at 12:49 PM
Gossamer Bio Announces Second Quarter 2020 Financial Results and Provides Corporate UpdateGossamer Bio Announces Second Quarter 2020 Financial Results and Provides Corporate Update
finance.yahoo.com - August 11 at 4:36 PM
Gossamer Bio Announces Data Presentations at the American Thoracic Society 2020 Virtual ConferenceGossamer Bio Announces Data Presentations at the American Thoracic Society 2020 Virtual Conference
finance.yahoo.com - August 5 at 10:36 AM
Could The Gossamer Bio, Inc. (NASDAQ:GOSS) Ownership Structure Tell Us Something Useful?Could The Gossamer Bio, Inc. (NASDAQ:GOSS) Ownership Structure Tell Us Something Useful?
finance.yahoo.com - July 22 at 2:33 PM
Gossamer Bios Shares March Higher, Can It Continue?Gossamer Bio's Shares March Higher, Can It Continue?
www.nasdaq.com - July 22 at 9:32 AM
Gossamer Bio's Shares March Higher, Can It Continue?Gossamer Bio's Shares March Higher, Can It Continue?
finance.yahoo.com - July 22 at 9:32 AM
Is Gossamer Bio, Inc. (GOSS) A Good Stock To Buy?Is Gossamer Bio, Inc. (GOSS) A Good Stock To Buy?
finance.yahoo.com - July 3 at 7:01 PM
BRIEF-Gossamer Bio Says Units Entered Into Second Amendment To Credit, Guaranty And Security AgreementBRIEF-Gossamer Bio Says Units Entered Into Second Amendment To Credit, Guaranty And Security Agreement
www.reuters.com - July 2 at 6:02 PM
Aerpio Hosting Key Opinion Leader Call on a Novel Mechanism for the Treatment of GlaucomaAerpio Hosting Key Opinion Leader Call on a Novel Mechanism for the Treatment of Glaucoma
finance.yahoo.com - June 8 at 12:28 PM
GOSS FINAL DEADLINE TODAY: Rosen, a Top Ranked Law Firm, Reminds Gossamer Bio, Inc. Investors of Important June 2 Deadline in Securities Class Action – GOSSGOSS FINAL DEADLINE TODAY: Rosen, a Top Ranked Law Firm, Reminds Gossamer Bio, Inc. Investors of Important June 2 Deadline in Securities Class Action – GOSS
finance.yahoo.com - June 2 at 12:41 PM
DEADLINE TODAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Gossamer Bio, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmDEADLINE TODAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Gossamer Bio, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
finance.yahoo.com - June 2 at 12:41 PM
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of GOSS, SERV and BBBYThe Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of GOSS, SERV and BBBY
finance.yahoo.com - June 2 at 12:41 PM
FINAL DEADLINE TODAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Gossamer Bio, Inc. and Encourages Investors with Losses to Contact the FirmFINAL DEADLINE TODAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Gossamer Bio, Inc. and Encourages Investors with Losses to Contact the Firm
finance.yahoo.com - June 2 at 12:41 PM
LAWSUITS FILED AGAINST GOSS, LBRT and FITB - JAKUBOWITZ LAW PURSUES SHAREHOLDERS CLAIMSLAWSUITS FILED AGAINST GOSS, LBRT and FITB - JAKUBOWITZ LAW PURSUES SHAREHOLDERS CLAIMS
finance.yahoo.com - June 2 at 12:41 PM
This page was last updated on 6/13/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.